A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...
A detailed overview of NeuroSalt's five-ingredient plant-based nerve health supplement - covering botanical formula ...
Algoma University’s Great Lakes International Summer Music Experience is turning its Sault Ste. Marie campus into a two-week ...
The Lanier Mansion State Historic Site in Madison is exactly that kind of place, a Greek Revival masterpiece that looks like ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.
New psychoactive substances (NPS) are a class of artificially designed and synthesized chemical substances designed to mimic the pharmacological effects of traditional drugs. They are characterized by ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results